Anna Krotkova

741 total citations
12 papers, 656 citations indexed

About

Anna Krotkova is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Anna Krotkova has authored 12 papers receiving a total of 656 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 2 papers in Molecular Biology and 2 papers in Oncology. Recurrent topics in Anna Krotkova's work include Immune Cell Function and Interaction (7 papers), T-cell and B-cell Immunology (6 papers) and Immunotherapy and Immune Responses (3 papers). Anna Krotkova is often cited by papers focused on Immune Cell Function and Interaction (7 papers), T-cell and B-cell Immunology (6 papers) and Immunotherapy and Immune Responses (3 papers). Anna Krotkova collaborates with scholars based in Germany, France and United Kingdom. Anna Krotkova's co-authors include Harald von Boehmer, Hans Jörg Fehling, Claude Saint‐Ruf, Katherine A. Forbush, Catherine Laplace, Roger M. Perlmutter, Klaus Eichmann, Brian M. Iritani, Ingrid Jakobsen Falk and Ian D. Haidl and has published in prestigious journals such as Nature, The Journal of Experimental Medicine and Journal of Clinical Oncology.

In The Last Decade

Anna Krotkova

11 papers receiving 645 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Krotkova Germany 7 531 215 195 31 26 12 656
Marianne Naspetti France 9 436 0.8× 179 0.8× 216 1.1× 50 1.6× 36 1.4× 10 647
Dalal El‐Khoury United States 8 514 1.0× 131 0.6× 126 0.6× 28 0.9× 19 0.7× 11 607
Erastus C. Dudley United States 4 519 1.0× 179 0.8× 173 0.9× 31 1.0× 72 2.8× 4 621
Geoffrey Catalano United States 4 309 0.6× 164 0.8× 213 1.1× 48 1.5× 21 0.8× 6 500
Linda Wu Canada 7 309 0.6× 138 0.6× 162 0.8× 18 0.6× 53 2.0× 8 433
Christine Broussard United States 7 375 0.7× 132 0.6× 190 1.0× 19 0.6× 35 1.3× 10 569
Ralph A. Reisfeld United States 7 265 0.5× 200 0.9× 158 0.8× 47 1.5× 31 1.2× 7 441
Marguerite Ragueneau France 6 456 0.9× 111 0.5× 151 0.8× 24 0.8× 65 2.5× 6 543
Inge S. van Houdt Netherlands 7 176 0.3× 183 0.9× 130 0.7× 21 0.7× 43 1.7× 8 346
L A Conroy United Kingdom 5 395 0.7× 75 0.3× 234 1.2× 15 0.5× 24 0.9× 7 480

Countries citing papers authored by Anna Krotkova

Since Specialization
Citations

This map shows the geographic impact of Anna Krotkova's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Krotkova with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Krotkova more than expected).

Fields of papers citing papers by Anna Krotkova

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Krotkova. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Krotkova. The network helps show where Anna Krotkova may publish in the future.

Co-authorship network of co-authors of Anna Krotkova

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Krotkova. A scholar is included among the top collaborators of Anna Krotkova based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Krotkova. Anna Krotkova is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Champiat, Stéphane, Patrick Grierson, Chia‐Hsun Hsieh, et al.. (2025). RHEA-1: First-in-human (FIH) study of AZD9793, a first-in-class CD8-guided T cell-engager (TCE) for glypican-3-positive (GPC3+) advanced or metastatic hepatocellular carcinoma (HCC).. Journal of Clinical Oncology. 43(16_suppl). 1 indexed citations
2.
Krotkova, Anna, et al.. (2015). Toxicity and Pharmacokinetics of novel IL-1 Trap heterodimeric fusion protein. Toxicology Letters. 238(2). S311–S311.
3.
Busse, Christian E., Anna Krotkova, & Klaus Eichmann. (2005). The TCRβ Enhancer Is Dispensable for the Expression of Rearranged TCRβ Genes in Thymic DN2/DN3 Populations but Not at Later Stages. The Journal of Immunology. 175(5). 3067–3074. 12 indexed citations
4.
Krotkova, Anna, et al.. (2004). Delayed and Restricted Expression Limits Putative Instructional Opportunities of Vγ1.1/Vγ2 γδ TCR in αβ/γδ Lineage Choice in the Thymus. The Journal of Immunology. 173(1). 25–32. 13 indexed citations
5.
Falk, Ingrid Jakobsen, et al.. (2001). Immature thymocytes that fail to express TCRβ and/or TCRγ δ proteins die by apoptotic cell death in the CD44-CD25- (DN4) subset. European Journal of Immunology. 31(11). 3308–3317. 31 indexed citations
6.
Fehling, Hans Jörg, Brian M. Iritani, Anna Krotkova, et al.. (1997). Restoration of Thymopoiesis in pTα−/− Mice by Anti-CD3ε Antibody Treatment or with Transgenes Encoding Activated Lck or Tailless pTα. Immunity. 6(6). 703–714. 94 indexed citations
8.
Fehling, Hans Jörg, Anna Krotkova, Claude Saint‐Ruf, & Harald von Boehmer. (1995). Crucial role of the pre-T-cell receptor α gene in development of ap but not γδ T cells. Nature. 375(6534). 795–798. 454 indexed citations
9.
Fehling, Hans Jörg, Anna Krotkova, Claude Saint‐Ruf, & Harald von Boehmer. (1995). Correction: Crucial role of the pre-T-cell receptor α gene in development of αβ but not γ§ T cells. Nature. 378(6555). 419–419. 10 indexed citations
10.
Krotkova, Anna, et al.. (1971). Physiology and biochemistry of ruminant digestion.. 1 indexed citations
11.
Krotkova, Anna, et al.. (1971). Physiology and biochemistry of digestion in ruminants.. 1 indexed citations
12.
Krotkova, Anna. (1959). Effect of sugar beet on acidosis in the ruminant.. 63–64. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026